Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2011, Article ID 467429, 14 pages
http://dx.doi.org/10.1155/2011/467429
Research Article

Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison

1Department of Toxicology, Clinical Research & Drug Safety Assessment, Pacira Pharmaceuticals Inc., San Diego, CA 92121, USA
2Pharmacokinetics, Mill Ridge Road, Raleigh, NC 27613, USA
3Toxicology Division, MPI Research Laboratories, North Main Street, Mattawan, MI 49071, USA

Received 16 June 2011; Accepted 1 August 2011

Academic Editor: Abdelwahab Omri

Copyright © 2011 Brigitte M. Richard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Angst and D. R. Drover, “Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology,” Clinical Pharmacokinetics, vol. 45, no. 12, pp. 1153–1176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. B. Scott, “Evaluation of the toxicity of local anaesthetic agents in man,” British Journal of Anaesthesia, vol. 47, no. 1, pp. 56–61, 1975. View at Google Scholar · View at Scopus
  3. J. X. Mazoit, E. E. Orhant, O. Boico, J. P. Kantelip, and K. Samii, “Myocardial uptake of bupivacaine: I. Pharmacokinetics and pharmacodynamics of lidocaine and bupivacaine in the isolated perfused rabbit heart,” Anesthesia and Analgesia, vol. 77, no. 3, pp. 469–476, 1993. View at Google Scholar · View at Scopus
  4. R. H. De Jong and J. D. Bonin, “Deaths from local anesthetic induced convulsions in mice,” Anesthesia and Analgesia, vol. 59, no. 6, pp. 401–405, 1980. View at Google Scholar · View at Scopus
  5. R. H. De Jong, R. A. Ronfeld, and R. A. DeRosa, “Cardiovascular effects of convulsant and supraconvulsant doses of amide local anesthetics,” Anesthesia and Analgesia, vol. 61, no. 1, pp. 3–9, 1982. View at Google Scholar · View at Scopus
  6. H. S. Feldman, G. R. Arthur, and B. G. Covino, “Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog,” Anesthesia and Analgesia, vol. 69, no. 6, pp. 794–801, 1989. View at Google Scholar · View at Scopus
  7. D. Fitzgibbons, D. C. Moore, and R. I. Balfour, “Convulsant blood levels of bupivacaine,” Anesthesiology, vol. 55, no. 4, p. 476, 1981. View at Google Scholar · View at Scopus
  8. G. T. Tucker and L. E. Mather, “Clinical pharmacokinetics of local anaesthetics,” Clinical Pharmacokinetics, vol. 4, no. 4, pp. 241–278, 1979. View at Google Scholar · View at Scopus
  9. S. Mantripragada, “A lipid based depot (DepoFoam® technology) for sustained release drug delivery,” Progress in Lipid Research, vol. 41, no. 5, pp. 392–406, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Denepitiya-Balicki and M. Punjala, “Extended-duration bupivacaine,” in The Essence of Analgesia and Analgesics, R. S. Sinatra, J. S. Jahr, and J. M. Watkins-Pitchford, Eds., chapter 118, pp. 471–475, Cambridge University Press, 2010. View at Google Scholar
  11. R. T. Skarda, “Local and regional anesthetic and analgesic techniques: dogs,” in Lumb & Jones’ Veterinary Anesthesia, J. C. Thurmaon, W. J. Tranquilli, and G. J. Benson, Eds., Williams & Wilkins, 3rd edition, 1996. View at Google Scholar
  12. J. G. Boogaerts, N. D. Lafont, H. Luo, and F. J. Legros, “Plasma concentrations of bupivacaine after brachial plexus administration of liposome-associated and plain solutions to rabbits,” Canadian Journal of Anaesthesia, vol. 40, no. 12, pp. 1201–1204, 1993. View at Google Scholar · View at Scopus
  13. N. A. Monteiro-Riviere, D. G. Bristol, T. O. Manning, R. A. Rogers, and J. E. Riviere, “Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species,” Journal of Investigative Dermatology, vol. 95, no. 5, pp. 582–586, 1990. View at Google Scholar · View at Scopus
  14. F. Henn and R. Brattsand, “Some pharmacological and toxicological properties of a new long-acting local analgesic, LAC-43 (marcaine), in comparison with mepivacaine and tetracaine,” Acta Anaesthesiologica Scandinavica, supplement 21, pp. 9–30, 1966. View at Google Scholar
  15. “Duocaine® package insert,” http://www.drugs.com/sfx/duocaine-side-effects.html.
  16. G. T. Tucker and L. E. Mather, “Clinical pharmacokinetics of local anaesthetics,” Clinical Pharmacokinetics, vol. 4, no. 4, pp. 241–278, 1979. View at Google Scholar · View at Scopus
  17. G. A. Albright, “Cardiac arrest following regional anesthesia with etidocaine or bupivacaine,” Anesthesiology, vol. 51, no. 4, pp. 285–287, 1979. View at Google Scholar · View at Scopus
  18. N. L. Davis and R. H. De Jong, “Successful resuscitation following massive bupivacaine overdose,” Anesthesia and Analgesia, vol. 61, no. 1, pp. 62–64, 1982. View at Google Scholar · View at Scopus
  19. M. E. Levsky and M. A. Miller, “Cardiovascular collapse from low dose bupivacaine,” Canadian Journal of Clinical Pharmacology, vol. 12, no. 3, pp. e240–e245, 2005. View at Google Scholar · View at Scopus
  20. M. D. Stoneham and S. E. P. Bree, “Epileptic seizure during awake carotid endarterectomy,” Anesthesia and Analgesia, vol. 89, no. 4, pp. 885–886, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Heavner, C. F. Dryden, V. Sanghani, G. Huemer, A. Bessire, and J. M. Badgwell, “Severe hypoxia enhances central nervous system and cardiovascular toxicity of bupivacaine in lightly anesthetized pigs,” Anesthesiology, vol. 77, no. 1, pp. 142–147, 1992. View at Google Scholar · View at Scopus
  22. J. E. Heavner, J. M. Badgwell, C. F. Dryden, and C. Flinders, “Bupivacaine toxicity in lightly anesthetized pigs with respiratory imbalances plus or minus halothane,” Regional Anesthesia, vol. 20, no. 1, pp. 20–26, 1995. View at Google Scholar · View at Scopus
  23. G. Weinberg, C. Paisanthasan, D. Feinstein, and W. Hoffman, “The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation,” Anesthesia and Analgesia, vol. 98, no. 3, pp. 790–795, 2004. View at Google Scholar · View at Scopus
  24. M. R. Blair, “Cardiovascular pharmacology of local anaesthetics,” British Journal of Anaesthesia, vol. 47, pp. 247–252, 1975. View at Google Scholar · View at Scopus
  25. R. A. Johns, W. C. Seyde, C. A. DiFazio, and D. E. Longnecker, “Dose-dependent effects of bupivacaine on rat muscle arterioles,” Anesthesiology, vol. 65, no. 2, pp. 186–191, 1986. View at Google Scholar · View at Scopus
  26. A. C. Santos, G. R. Arthur, D. J. Roberts et al., “Effect of ropivacaine and bupivacaine on uterine blood flow in pregnant ewes,” Anesthesia and Analgesia, vol. 74, no. 1, pp. 62–67, 1992. View at Google Scholar · View at Scopus
  27. E. U. M. Nyström, J. E. Heavner, and C. W. Buffington, “Blood pressure is maintained despite profound myocardial depression during acute bupivacaine overdose in pigs,” Anesthesia and Analgesia, vol. 88, no. 5, pp. 1143–1148, 1999. View at Publisher · View at Google Scholar
  28. Y. Oda, T. Funao, K. Tanaka, and A. Asada, “Vasodilation increases the threshold for bupivacaine-induced convulsions in rats,” Anesthesia and Analgesia, vol. 98, no. 3, pp. 677–682, 2004. View at Google Scholar · View at Scopus
  29. C. Nancarrow, A. J. Rutten, W. G. Runciman et al., “Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bipuvacaine, and ropivacaine in the sheep,” Anesthesia and Analgesia, vol. 69, no. 3, pp. 276–283, 1989. View at Google Scholar
  30. A. J. Rutten, C. Nancarrow, L. E. Mather, A. H. Ilsley, W. B. Runciman, and R. N. Upton, “Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep,” Anesthesia and Analgesia, vol. 69, no. 3, pp. 291–299, 1989. View at Google Scholar · View at Scopus
  31. Y. F. Huang, M. E. Pryor, L. E. Mather, and B. T. Veering, “Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep,” Anesthesia and Analgesia, vol. 86, no. 4, pp. 797–804, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. D. H. T. Chang, L. A. Ladd, K. A. Wilson, L. Gelgor, and L. E. Mather, “Tolerability of large-dose intravenous levobupivacaine in sheep,” Anesthesia and Analgesia, vol. 91, no. 3, pp. 671–679, 2000. View at Google Scholar · View at Scopus
  33. D. H. T. Chang, L. A. Ladd, S. Copeland, M. A. Iglesias, J. L. Plummer, and L. E. Mather, “Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep,” British Journal of Pharmacology, vol. 132, no. 3, pp. 649–658, 2001. View at Google Scholar · View at Scopus
  34. L. A. Ladd and L. E. Mather, “Central Effects Index—A semiquantitative method for the assessment of CNS toxicity of local anaesthetic agents in sheep,” Journal of Pharmacological and Toxicological Methods, vol. 44, no. 3, pp. 467–476, 2000. View at Publisher · View at Google Scholar
  35. L. A. Ladd, D. H. T. Chang, K. A. Wilson, S. E. Copeland, J. L. Plummer, and L. E. Mather, “Effects of CNS site-directed carotid arterial infusions of bupivacaine, levobupivacaine, and ropivacaine in sheep,” Anesthesiology, vol. 97, no. 2, pp. 418–428, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. L. E. Mather, “Disposition of mepivacaine and bupivacaine enantiomers in sheep,” British Journal of Anaesthesia, vol. 67, no. 3, pp. 239–246, 1991. View at Google Scholar · View at Scopus
  37. L. E. Mather and D. H. T. Chang, “Cardiotoxicity with modern local anaesthetics: is there a safer choice?” Drugs, vol. 61, no. 3, pp. 333–342, 2001. View at Google Scholar · View at Scopus
  38. L. E. Mather, “The acute toxicity of local anesthetics,” Expert Opinion on Drug Metabolism and Toxicology, vol. 6, no. 11, pp. 1313–1332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Pirotta and J. Sprigge, “Convulsions following axillary brachial plexus blockade with levobupivacaine,” Anaesthesia, vol. 57, no. 12, pp. 1187–1189, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. A. H. Chen, “Toxicity and allergy to local anesthesia,” Journal of the California Dental Association, vol. 26, no. 9, pp. 683–692, 1998. View at Google Scholar · View at Scopus
  41. S. Englesson, “The influence of acid base changes on central nervous system toxicity of local anaesthetic agents I. An experimental study in cats,” Acta Anaesthesiologica Scandinavica, vol. 18, no. 2, pp. 79–87, 1974. View at Google Scholar · View at Scopus
  42. National Toxicology Program, “Local anesthetics that metabolize to 2,6-Xylidine or o-Toluidine,” NIEHS Contract Number N01-ES- 65402 , 2000, http://ntp.niehs.nih.gov/.
  43. G. A. Albright, “Cardiac arrest following regional anesthesia with etidocaine or bupivacaine,” Anesthesiology, vol. 51, no. 4, pp. 285–287, 1979. View at Google Scholar · View at Scopus
  44. N. L. Davis and R. H. De Jong, “Successful resuscitation following massive bupivacaine overdose,” Anesthesia and Analgesia, vol. 61, no. 1, pp. 62–64, 1982. View at Google Scholar · View at Scopus
  45. R. H. De Jong and J. D. Bonin, “Deaths from local anesthetic induced convulsions in mice,” Anesthesia and Analgesia, vol. 59, no. 6, pp. 401–405, 1980. View at Google Scholar · View at Scopus
  46. R. H. De Jong, R. A. Ronfeld, and R. A. DeRosa, “Cardiovascular effects of convulsant and supraconvulsant doses of amide local anesthetics,” Anesthesia and Analgesia, vol. 61, no. 1, pp. 3–9, 1982. View at Google Scholar · View at Scopus
  47. “Sensorcaine® package insert,” http://www.drugs.com/pro/bupivacaine.html.
  48. H. S. Feldman, G. R. Arthur, and B. G. Covino, “Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog,” Anesthesia and Analgesia, vol. 69, no. 6, pp. 794–801, 1989. View at Google Scholar · View at Scopus
  49. R. D. Thomas, M. M. Behbehani, D. E. Coyle, and D. D. Denson, “Cardiovascular toxicity of local anesthetics: an alternative hypothesis,” Anesthesia and Analgesia, vol. 65, no. 5, pp. 444–450, 1986. View at Google Scholar · View at Scopus
  50. P. Pere, H. Watanabe, M. Pitkanen, T. Wahlstrom, and P. H. Rosenberg, “Local myotoxicity of bupivacaine in rabbits after continuous supraclavicular brachial plexus block,” Regional Anesthesia, vol. 18, no. 5, pp. 304–307, 1993. View at Google Scholar · View at Scopus
  51. W. Zink, J. R. E. Bohl, N. Hacke, B. Sinner, E. Martin, and B. M. Graf, “The long term myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blocks,” Anesthesia and Analgesia, vol. 101, no. 2, pp. 548–554, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Padera, E. Bellas, J. Y. Tse, D. Hao, and D. S. Kohane, “Local myotoxicity from sustained release of bupivacaine from microparticles,” Anesthesiology, vol. 108, no. 5, pp. 921–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. Q. Hogan, R. Dotson, S. Erickson, R. Kettler, and K. Hogan, “Local anesthetic myotoxicity: a case and review,” Anesthesiology, vol. 80, no. 4, pp. 942–947, 1994. View at Google Scholar · View at Scopus
  54. G. T. Tucker, “Pharmacokinetics of local anaesthetics,” British Journal of Anaesthesia, vol. 58, no. 7, pp. 717–731, 1986. View at Google Scholar · View at Scopus